Cdk5/p25, active
Complex of N-terminal 6His-tagged recombinant, human full length cdk5 and N-terminal GST-tagged recombinant, human full length p25.
Biological information
Background
Cyclin-dependent Kinase 5 (cdk5) is a cyclin-dependent serine/threonine kinase that, while not involved in cell proliferation, plays a critical role in neuron development. The kinase is activated strongly when it complexes with neuron-specific activators, especially p35, but less strongly when it complexes with cyclins. In contrast, a constitutively active form of the complex results when cdk5 binds with p25 or p21 (truncated forms of p35). The cdk5/p35 complex has been implicated in neurite outgrowth, neuronal differentiation and neuronal migration and axon patterning. The complex phosphorylates the tau protein at Ser199, Ser202 and Thr205. Hyperphosphorylated tau will cause neurofibrillary tangles and lead to Alzheimer's disease. Research has also shown the cdk5/p35 complex is associated with drug addiction and amyotrophic lateral sclerosis. Inhibitors may prevent the progression of Alzheimer’s disease, amyotrophic lateral sclerosis, and other neurodegenerative diseases.
GenBank X66364 / p25 is an in vivo cleavage product of the p35 protein described inGenBank X80343. The recombinant product contains the full length p25 protein, equivalent to residues F98–end of p35, as described in Gentry et al., Nature 402, 615-622, 1999.
Target class
Kinase
Family
CMGC
Accession number
NM_004935.2
Target Name
Cdk5/p25, active
Target Alias
CDK5, PSSALRE
Origin
Human
Theori. MW
34.4 kDa (cdk5), 49.4 kDa (p25)
Affinity tag
GST, 6His
Product specifications
Expression system
Expressed by baculovirus in Sf21 insect cells
Purity
Refer to CoA for Purity
Purification method
Ni2+/NTA-agarose
Sample Buffer
Specified activity
Refer to CoA
Application
For Research Only
Storage conditions
1 year at -70°C
Usage disclaimer
For Research Only
Chemical data
Background
Cyclin-dependent Kinase 5 (cdk5) is a cyclin-dependent serine/threonine kinase that, while not involved in cell proliferation, plays a critical role in neuron development. The kinase is activated strongly when it complexes with neuron-specific activators, especially p35, but less strongly when it complexes with cyclins. In contrast, a constitutively active form of the complex results when cdk5 binds with p25 or p21 (truncated forms of p35). The cdk5/p35 complex has been implicated in neurite outgrowth, neuronal differentiation and neuronal migration and axon patterning. The complex phosphorylates the tau protein at Ser199, Ser202 and Thr205. Hyperphosphorylated tau will cause neurofibrillary tangles and lead to Alzheimer's disease. Research has also shown the cdk5/p35 complex is associated with drug addiction and amyotrophic lateral sclerosis. Inhibitors may prevent the progression of Alzheimer’s disease, amyotrophic lateral sclerosis, and other neurodegenerative diseases.
GenBank X66364 / p25 is an in vivo cleavage product of the p35 protein described inGenBank X80343. The recombinant product contains the full length p25 protein, equivalent to residues F98–end of p35, as described in Gentry et al., Nature 402, 615-622, 1999.
Compound name
Kinase
Catalog number
14-516
Molecular formula
CAS
MW
Ka
Percent composition
Product specifications
Physical state
Purity (HPLC 214nm)
Retention time (RP18 HPLC)
CMC
Exact mass
Stability
For Research Only
Solubility structure
Datasheets
14-516
Datasheet